Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24574538 | 0.96 | TUBB1 (0.47) | TUBB1KDM4EHPGDHSD17B10 | |
| SCHEMBL22316538 | 0.91 | TUBB1 (0.48) | TUBB1ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL22315956 | 0.89 | TUBB1 (0.47) | TUBB1ALDH1A1SMN1; SMN2 | |
| SCHEMBL24410216 | 0.89 | TUBB1 (0.45) | TUBB1 | |
| SCHEMBL22316494 | 0.89 | TUBB1 (0.47) | TUBB1ALDH1A1SMN1; SMN2 | |
| SCHEMBL24410219 | 0.89 | TUBB1 (0.45) | TUBB1 | |
| SCHEMBL24574723 | 0.89 | TUBB1 (0.45) | TUBB1 | |
| SCHEMBL22315958 | 0.89 | TUBB1 (0.49) | TUBB1ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL24574908 | 0.89 | TUBB1 (0.45) | TUBB1 | |
| SCHEMBL24574907 | 0.89 | TUBB1 (0.45) | TUBB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220202948-A1 | Agent for Eliminating Pluripotent Stem Cells | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2022-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220202948-A1 | Agent for Eliminating Pluripotent Stem Cells | POU5F1, POU2F1, POU2F2 | TUBB1 119/4885ALDH1A1 24/4885SMN1; SMN2 1115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.